Non-steroidal anti-inflammatory drugs in general practice: A decision-making dilemma

Suzi S. Mikhail, Nicholas A. Zwar, Sanjyot Vagholkar, Sarah M. Dennis, Richard O. Day

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Abstract

Objectives: To examine the effect of the debate on the safety of non-steroidal anti-inflammatory drugs (NSAIDs) on decision making by Australian general practitioners and patients with osteoarthritis (OA), and to explore issues concerning the use of NSAIDs from both prescriber and consumer perspectives. Design and setting: A qualitative study in which five focus groups (three for GPs, and two for patients with OA) were conducted between 15 May and 4 August 2006 in south-western Sydney. Participants: Five advanced general practice registrars, six experienced GP5, and 20 patients with OA aged 54-85 years. Main outcome measures: Key themes and issues identified by content analysis of focus group transcripts. Results: GPs reported adopting a cautious approach to prescribing NSAIDs because of uncertainty about safety and medicolegal concerns. They were sceptical about information provided by the pharmaceutical industry and found the literature about the safety of NSAIDs confusing. Time was identified as a major barrier to adequate discussion with patients, and explaining the risk to patients in a meaningful way was perceived as a challenge. Patients wanted information and sought it from a range of sources, most commonly pharmacists and GPs. Most patients made active decisions about using or not using NSAIDs, with some favouring physical function over safety. Patients were also using other forms of treatment including alternative medicine. Conclusion: Our findings reflect the need to provide clear, unbiased information about NSAIDs to help both GPs and patients negotiate this decision-making dilemma.

Original languageEnglish
Pages (from-to)160-163
Number of pages4
JournalMedical Journal of Australia
Volume187
Issue number3
Publication statusPublished - 6 Aug 2007
Externally publishedYes

Fingerprint

General Practice
Decision Making
Anti-Inflammatory Agents
Pharmaceutical Preparations
Osteoarthritis
Safety
Focus Groups
Drug Industry
Complementary Therapies
Pharmacists
General Practitioners
Uncertainty
Outcome Assessment (Health Care)

Cite this

Mikhail, S. S., Zwar, N. A., Vagholkar, S., Dennis, S. M., & Day, R. O. (2007). Non-steroidal anti-inflammatory drugs in general practice: A decision-making dilemma. Medical Journal of Australia, 187(3), 160-163.
Mikhail, Suzi S. ; Zwar, Nicholas A. ; Vagholkar, Sanjyot ; Dennis, Sarah M. ; Day, Richard O. / Non-steroidal anti-inflammatory drugs in general practice : A decision-making dilemma. In: Medical Journal of Australia. 2007 ; Vol. 187, No. 3. pp. 160-163.
@article{d2764f4216e34a5cac0d8afe6d4ce195,
title = "Non-steroidal anti-inflammatory drugs in general practice: A decision-making dilemma",
abstract = "Objectives: To examine the effect of the debate on the safety of non-steroidal anti-inflammatory drugs (NSAIDs) on decision making by Australian general practitioners and patients with osteoarthritis (OA), and to explore issues concerning the use of NSAIDs from both prescriber and consumer perspectives. Design and setting: A qualitative study in which five focus groups (three for GPs, and two for patients with OA) were conducted between 15 May and 4 August 2006 in south-western Sydney. Participants: Five advanced general practice registrars, six experienced GP5, and 20 patients with OA aged 54-85 years. Main outcome measures: Key themes and issues identified by content analysis of focus group transcripts. Results: GPs reported adopting a cautious approach to prescribing NSAIDs because of uncertainty about safety and medicolegal concerns. They were sceptical about information provided by the pharmaceutical industry and found the literature about the safety of NSAIDs confusing. Time was identified as a major barrier to adequate discussion with patients, and explaining the risk to patients in a meaningful way was perceived as a challenge. Patients wanted information and sought it from a range of sources, most commonly pharmacists and GPs. Most patients made active decisions about using or not using NSAIDs, with some favouring physical function over safety. Patients were also using other forms of treatment including alternative medicine. Conclusion: Our findings reflect the need to provide clear, unbiased information about NSAIDs to help both GPs and patients negotiate this decision-making dilemma.",
author = "Mikhail, {Suzi S.} and Zwar, {Nicholas A.} and Sanjyot Vagholkar and Dennis, {Sarah M.} and Day, {Richard O.}",
year = "2007",
month = "8",
day = "6",
language = "English",
volume = "187",
pages = "160--163",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "AUSTRALASIAN MED PUBL CO LTD",
number = "3",

}

Mikhail, SS, Zwar, NA, Vagholkar, S, Dennis, SM & Day, RO 2007, 'Non-steroidal anti-inflammatory drugs in general practice: A decision-making dilemma' Medical Journal of Australia, vol. 187, no. 3, pp. 160-163.

Non-steroidal anti-inflammatory drugs in general practice : A decision-making dilemma. / Mikhail, Suzi S.; Zwar, Nicholas A.; Vagholkar, Sanjyot; Dennis, Sarah M.; Day, Richard O.

In: Medical Journal of Australia, Vol. 187, No. 3, 06.08.2007, p. 160-163.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Non-steroidal anti-inflammatory drugs in general practice

T2 - A decision-making dilemma

AU - Mikhail, Suzi S.

AU - Zwar, Nicholas A.

AU - Vagholkar, Sanjyot

AU - Dennis, Sarah M.

AU - Day, Richard O.

PY - 2007/8/6

Y1 - 2007/8/6

N2 - Objectives: To examine the effect of the debate on the safety of non-steroidal anti-inflammatory drugs (NSAIDs) on decision making by Australian general practitioners and patients with osteoarthritis (OA), and to explore issues concerning the use of NSAIDs from both prescriber and consumer perspectives. Design and setting: A qualitative study in which five focus groups (three for GPs, and two for patients with OA) were conducted between 15 May and 4 August 2006 in south-western Sydney. Participants: Five advanced general practice registrars, six experienced GP5, and 20 patients with OA aged 54-85 years. Main outcome measures: Key themes and issues identified by content analysis of focus group transcripts. Results: GPs reported adopting a cautious approach to prescribing NSAIDs because of uncertainty about safety and medicolegal concerns. They were sceptical about information provided by the pharmaceutical industry and found the literature about the safety of NSAIDs confusing. Time was identified as a major barrier to adequate discussion with patients, and explaining the risk to patients in a meaningful way was perceived as a challenge. Patients wanted information and sought it from a range of sources, most commonly pharmacists and GPs. Most patients made active decisions about using or not using NSAIDs, with some favouring physical function over safety. Patients were also using other forms of treatment including alternative medicine. Conclusion: Our findings reflect the need to provide clear, unbiased information about NSAIDs to help both GPs and patients negotiate this decision-making dilemma.

AB - Objectives: To examine the effect of the debate on the safety of non-steroidal anti-inflammatory drugs (NSAIDs) on decision making by Australian general practitioners and patients with osteoarthritis (OA), and to explore issues concerning the use of NSAIDs from both prescriber and consumer perspectives. Design and setting: A qualitative study in which five focus groups (three for GPs, and two for patients with OA) were conducted between 15 May and 4 August 2006 in south-western Sydney. Participants: Five advanced general practice registrars, six experienced GP5, and 20 patients with OA aged 54-85 years. Main outcome measures: Key themes and issues identified by content analysis of focus group transcripts. Results: GPs reported adopting a cautious approach to prescribing NSAIDs because of uncertainty about safety and medicolegal concerns. They were sceptical about information provided by the pharmaceutical industry and found the literature about the safety of NSAIDs confusing. Time was identified as a major barrier to adequate discussion with patients, and explaining the risk to patients in a meaningful way was perceived as a challenge. Patients wanted information and sought it from a range of sources, most commonly pharmacists and GPs. Most patients made active decisions about using or not using NSAIDs, with some favouring physical function over safety. Patients were also using other forms of treatment including alternative medicine. Conclusion: Our findings reflect the need to provide clear, unbiased information about NSAIDs to help both GPs and patients negotiate this decision-making dilemma.

UR - http://www.scopus.com/inward/record.url?scp=34548171939&partnerID=8YFLogxK

M3 - Article

VL - 187

SP - 160

EP - 163

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 3

ER -